George J. Walsh III

All filings by George J. Walsh III on record concern Chemed Corp, in the capacity of board member. The record holds 57 filings, for trades running from 20 November 2007 to 29 May 2026.

In open-market terms, that means 32 purchases worth €575k on one side and 14 sales worth €3.2M on the other. On balance, insiders were net sellers of €2.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 11 share grants. So far in 2026, the count stands at no purchases and 1 sale.

Half of the purchases are above €3,758 and half below. None of the 13 purchases we analysed coincided with buying by another insider of the same company within 30 days. Looking at 26 purchases old enough to measure, the stock rose over the following 90 days in 69% of cases; the median change was +5.4%. These figures describe past trades and do not predict future prices.

Most recently, on 29 May 2026, the filings show an open-market sale worth €188k in Chemed Corp. The latest purchase dates back some time: it was published 460 days ago, on 5 August 2025. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.